Could Vaccines Be a Possible Model for Pediatric Drug Development?

2:00 pm

Walter Orenstein, MD

Vaccine Adverse Event Reporting System

2:15 pm

Discussion

2:45 pm

Break

Current Models and Alternative Approaches

3:00 pm

European Union Legislation

Annic Weyersberg, MD

European Agency for the Evaluation of Medicinal Products

3:15 pm

St. Jude’s Approach to Addressing the Institute of Medicine Report: Making Better Drugs for Children with Cancer

William Evans, PharmD

St. Jude Children’s Research Hospital

3:30 pm

Discussion

Identification of Actions

4:00 pm

Conclusions and Next Steps for the Institute of Medicine Drug Forum

4:30 pm

Adjourn



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement